We are live on ! Find out more
D.E. Shaw & Co

D.E. Shaw & Co Portfolio holdings

AUM $166B
1-Year Est. Return 43.98%
 

D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.

This Fund
S&P 500
This Quarter Est. Return
+14.94%
1 Year Est. Return
+43.98%
3 Year Est. Return
+138.44%
5 Year Est. Return
+164.23%
10 Year Est. Return
+713.02%
AUM
$114B
AUM Growth
+$18.7B
Cap. Flow
+$1.27B
Cap. Flow %
1.11%
Top 10 Hldgs %
12.43%
Holding
4,806
New
575
Increased
1,549
Reduced
1,464
Closed
527

Sector Composition

Rank Sector Weight
1 Technology 17.03%
2 Consumer Discretionary 9.51%
3 Healthcare 5.76%
4 Financials 5.47%
5 Communication Services 4.87%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MRVI icon
1401
Maravai LifeSciences
MRVI
$987M
$8.07M 0.01%
1,232,499
+463,246
+60% +$2.99M
GVA icon
1402
Granite Construction
GVA
$5.49B
$8.07M 0.01%
158,669
+95,068
+149% +$4.15M
SKT icon
1403
Tanger
SKT
$4.8B
$8.07M 0.01%
291,072
-13,965
-5% -$348K
WCC
1404
CALL
WESCO International
WCC
$16.5B
$8.07M 0.01%
46,400
-10,000
-18% -$1.5M
EQIX icon
1405
CALL
Equinix
EQIX
$103B
$8.05M 0.01%
10,000
AMLX icon
1406
Amylyx Pharmaceuticals
AMLX
$2.17B
$8.05M 0.01%
546,965
-213,325
-28% -$3.27M
SU icon
1407
Suncor Energy
SU
$75.6B
$8.03M 0.01%
250,608
-666,686
-73% -$21.8M
JBGS
1408
JBG SMITH
JBGS
$832M
$8.02M 0.01%
471,353
+131,567
+39% +$1.92M
SYF icon
1409
PUT
Synchrony
SYF
$24.5B
$8.01M 0.01%
+209,800
New +$6.64M
RXST icon
1410
RxSight
RXST
$233M
$8.01M 0.01%
198,570
+110,283
+125% +$3.23M
ATKR icon
1411
Atkore
ATKR
$2.54B
$8.01M 0.01%
50,034
-40,867
-45% -$5.64M
AGCO icon
1412
AGCO
AGCO
$8.71B
$8M 0.01%
65,893
-31,451
-32% -$3.68M
DPZ icon
1413
CALL
Domino's
DPZ
$11.4B
$8M 0.01%
19,400
+600
+3% +$225K
INFA
1414
DELISTED
Informatica
INFA
$8M 0.01%
281,646
+241,634
+604% +$5.81M
NDAQ icon
1415
Nasdaq
NDAQ
$52.5B
$7.99M 0.01%
137,485
+54,041
+65% +$2.85M
PLL
1416
CALL
DELISTED
Piedmont Lithium
PLL
$7.98M 0.01%
282,800
+260,400
+1,163% +$7.65M
MATX icon
1417
Matsons
MATX
$6.22B
$7.98M 0.01%
72,838
+38,064
+109% +$3.61M
SHAK icon
1418
CALL
Shake Shack
SHAK
$2.48B
$7.98M 0.01%
107,700
+44,200
+70% +$2.71M
MDGL icon
1419
CALL
Madrigal Pharmaceuticals
MDGL
$12.7B
$7.98M 0.01%
34,500
+10,000
+41% +$1.75M
OSK icon
1420
PUT
Oshkosh
OSK
$9.66B
$7.98M 0.01%
73,600
+55,900
+316% +$5.41M
APO icon
1421
CALL
Apollo Global Management
APO
$71.6B
$7.96M 0.01%
85,400
SON icon
1422
Sonoco
SON
$5.8B
$7.96M 0.01%
142,427
-6,070
-4% -$329K
NVEI
1423
CALL
DELISTED
Nuvei Corporation Subordinate Voting Shares
NVEI
$7.95M 0.01%
302,600
+195,900
+184% +$3.76M
LUNG icon
1424
Pulmonx
LUNG
$51.5M
$7.94M 0.01%
622,588
-45,770
-7% -$477K
FFWM
1425
DELISTED
First Foundation Inc
FFWM
$7.94M 0.01%
819,750
+35,739
+5% +$228K

Similar funds

D.E. Shaw & Co's Q4 2023 Portfolio in Review

As of Q4 2023, D.E. Shaw & Co held 4,806 positions worth $114B, up 19% from $95.8B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

D.E. Shaw & Co's Q4 2023 filing shows 575 new, 1,549 increased, 1,464 reduced and 527 closed positions. Its largest new stake was iShares iBoxx $ High Yield Corporate Bond ETF: 2,424,593 shares worth $188M. The largest sale was Horizon Therapeutics Public Limited Company Ordinary Shares, an estimated $546M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 17% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • D.E. Shaw & Co's largest Q4 2023 buy was iShares iBoxx $ High Yield Corporate Bond ETF: 2,424,593 shares worth $188M.
  • D.E. Shaw & Co added most to Netflix in Q4 2023, an estimated $751M increase.
  • D.E. Shaw & Co's biggest Q4 2023 reduction was Microsoft, cutting an estimated $336M.
  • D.E. Shaw & Co fully exited Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2023, selling an estimated $546M.
  • D.E. Shaw & Co's ten largest holdings make up 12% of its $114B portfolio in Q4 2023.
  • D.E. Shaw & Co opened 575 new positions and closed 527 in Q4 2023.
  • D.E. Shaw & Co's portfolio value rose 19% quarter-over-quarter to $114B.

Based on D.E. Shaw & Co's 13F filing for Q4 2023, filed 14 Feb 2024.